StockData
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. (EBS) stock

EBSNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3074% below fair value
$5.50−0.11 (-1.96%)

Close on Nov 18, 2026Market cap $282.00MP/E –Yield –

Emergent BioSolutions pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Emergent BioSolutions's pe ratio was 8.8× on Apr 30, 2026, against 12.3× a year earlier. Over the last 5 years it ranged from 3.4× to 787.0×, with a median of 16.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20268.8×−0.7
2025Dec 31, 20259.5×−9.3
2023Jan 31, 202318.8×+2.0
2022Dec 30, 202216.9×+5.8
2021Dec 31, 202111.1×−17.6
2020Dec 31, 202028.7×−742.0
2019Dec 31, 2019770.7×+740.5
2018Dec 31, 201830.2×+4.3
2017Dec 29, 201726.0×−7.2
2016Dec 30, 201633.2×−0.2
2015Dec 31, 201533.3×−23.4
2014Dec 31, 201456.7×+21.4
2013Dec 31, 201335.4×+16.3
2012Dec 31, 201219.1×−9.9
2011Dec 30, 201129.0×+5.3
2010Dec 31, 201023.7×–

More Emergent BioSolutions figures

See a number that looks wrong?